Option chain shows key data for GlucoTrack's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for GlucoTrack.

GlucoTrack (NASDAQ:GCTK) Stock, Option Chain

GlucoTrack

GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on proven healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.

Diabetes research

News

Health Care

Movers

Trading Ideas

General

GCTK

Glucotrack reported positive clinical results for its implantable glucose monitor, aiming to offer a less-intrusive option for diabetes management.

Why Is This Nano-Cap Glucotrack Stock Trading Higher On Wednesday?

Screenshot 2025-06-09 at 5.40.14 PM

Movers & Shakers

Rebuilding Trust: How Glucotrack Is Establishing A New Standard In Diabetes Management

Screenshot 2025-05-28 at 7.18.26 PM

Upcoming Benzinga Webinar With Glucotrack To Discuss The Potential Of Its Innovative CBGM Technology To Transform Diabetes Care And Patient Lives

GlucoTrack Inc

Press Releases

Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights

Contracts

Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor

Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas

Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor

Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development

Management

Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD

Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions

Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements

Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions

RBOT

Aethlon Medical

Autonomix Medical

Bluejay Diagnostics

Biomerica

Co-Diagnostics

Ekso Bionics Holdings, Inc. - Common Stock

Ekso Bionics Holdings

HeartSciences

Helius Medical Technologies, Inc. - Class A Common Stock

Helius Medical Tech

SeaStar Medical Holding Corporation - Common Stock

SeaStar Medical Holding

INVO Fertility

NanoVibronix

ENDRA Life Sciences

Nuwellis

Predictive Oncology

ReShape Lifesciences, Inc. - Common Stock

Reshape Lifesciences

SINTX Technologies

Tivic Health Systems, Inc. - Common stock

Tivic Health Systems

Tenon Medical

Venus Concept

Catheter Precision

Xylo Technologies Ltd. - American Depositary Shares

Xylo Technologies

Screenshot 2025-05-13 at 5.40.09 PM

First-In-Human Study In The Bag, Glucotrack Gears Up For Long-Term Trial Of Potentially Groundbreaking Continuous Blood Glucose Monitor For Diabetes Patients

Screenshot 2025-03-18 at 5.54.31 PM

Implantable, Hidden Continuous Glucose Monitoring Could Revolutionize Diabetes Care

Screenshot 2025-02-24 at 6.22.23 PM

Biotech

DXCM

Glucotrack Commences Transition From Concept To Reality With Breakthrough Clinical Trial

Screenshot 2025-01-06 at 6.34.13 PM

Advancing Clinical Studies, Meeting Regulatory Milestones, Strengthening Its Strategic Framework And More: The Past Year For Glucotrack, And What Lies Ahead

Screenshot 2024-12-03 at 7.43.04 PM

Driving Innovation In Diabetes Management: Glucotrack Begins Enrollment For Human Clinical Trials For Its Implantable Continuous Blood Glucose Monitor

Screenshot 2024-10-03 at 5.30.47 PM

SENS

Expanding Continuous Glucose Monitoring Options: How Glucotrack Is Helping Usher In The Next Generation Of Diabetes Care Technology

Screenshot 2024-08-23 at 5.43.44 PM

Poster Presentations, Upcoming Human Trials, Recently Secured Funding And More: Glucotrack&#39;s Plans To Transform The Continuous Glucose Monitoring Market

Continuous Blood Glucose Monitoring Can Materially Improve The Quality Of Life For People With Diabetes – Glucotrack Wants To Make It Easier

Comments

GlucoTrack

GlucoTrack (GCTK) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell